Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
Medtronic (MDT) Stock Price & Analysis
5,285 Followers
MDT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$67.71 - $88.74
Previous Close$84.3
Volume2.91M
Average Volume (3M)6.16M
Market Cap
$111.63B
Enterprise Value$129.00B
Total Cash (Recent Filing)$8.32B
Total Debt (Recent Filing)$25.18B
Price to Earnings (P/E)26.7
Beta0.62
Next Earnings
May 23, 2024EPS Estimate
$1.45Last Dividend Ex-Date
Mar 21, 2024Dividend Yield3.27%
Share Statistics
EPS (TTM)3.15
Shares Outstanding1,327,822,539
10 Day Avg. Volume5,068,538
30 Day Avg. Volume6,159,539
Standard Deviation0.07
R-Squared0.41
Alpha-0.00553
Financial Highlights & Ratios
Price to Book (P/B)-35.97
Price to Sales (P/S)12.98
Price to Cash Flow (P/CF)11.10
P/FCF Ratio12.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.99
Enterprise Value/Gross Profit6.29
Enterprise Value/Ebitda25.56
Forecast
1Y Price Target
$93.87Price Target Upside11.66% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Medtronic News
Bulls Say, Bears Say
Bulls Say
Clinical TrialsThe first-in-human data for the Affera Sphere-360 PFA catheter showed high rates of freedom from atrial arrhythmias and sustained lesion durability, indicating a strong safety and efficacy profile.
Financial PerformanceMDT raised its organic sales growth guidance and now projects higher earnings per share, demonstrating confidence in the company's future financial performance.
Product DevelopmentFDA approved MDT's next generation TAVR device, Evolut FX Plus, which improves coronary access and has features that make it more competitive.
Bears Say
Clinical TrialsWhile MDT has not posted specifics on the Expand-URO clinical trial to clinicaltrials.gov, MDT has noted previously that the trial is enrolling 122 patients at 6 sites in the US.
Market CompetitionLaunching a competitive robotic system to ISRG with only one indication (i.e. urology) would be inferior in the market.
Product PerformanceMore challenging coronary access for future procedures has been a drawback for MDT's Evolut platform relative to competitors.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
MDT FAQ
What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $67.71 and its highest was $88.74 in the past 12 months.
What is Medtronic’s market cap?
Currently, no data Available
When is Medtronic’s upcoming earnings report date?
Medtronic’s upcoming earnings report date is May 23, 2024 which is in 8 days.
How were Medtronic’s earnings last quarter?
Medtronic released its earnings results on Feb 20, 2024. The company reported $1.3 earnings per share for the quarter, beating the consensus estimate of $1.262 by $0.038.
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic pays a Quarterly dividend of $0.69 which represents an annual dividend yield of 3.27%. See more information on Medtronic dividends here
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate is $1.45.
How many shares outstanding does Medtronic have?
Medtronic has 1,327,822,500 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Medtronic reported an EPS of $1.3 in its last earnings report, beating expectations of $1.262. Following the earnings report the stock price went up 1.684%.
Which hedge fund is a major shareholder of Medtronic?
Among the largest hedge funds holding Medtronic’s share is First Eagle Investment Management LLC. It holds Medtronic’s shares valued at 775M.
---
Medtronic Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$93.87 (11.66% Upside)
$93.87 (11.66% Upside)
Blogger Sentiment
Bullish
MDT Sentiment 92%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 7.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 2.7%
Last 30 Days ▼ 2.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.97%
12-Months-Change
Fundamentals
Return on Equity
8.14%
Trailing 12-Months
Asset Growth
-3.50%
Trailing 12-Months
Company Description
Medtronic
Founded in 1949, Medtronic Plc, a medical technology company, develops, manufactures, distributes, and sells device-based medical therapies and services worldwide. It operates through four segments, including Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The company is headquartered in Dublin, Ireland.
---
MDT Company Deck
---
MDT Earnings Call
Q3 2024
0:00 / 0:00
---
MDT Net sales Breakdown
37.06% Cardiovascular
28.69% Neuroscience
27.01% Medical Surgical
7.24% Diabetes
---
MDT Stock 12 Month Forecast
Average Price Target
$93.87
▲(11.66% Upside)
Technical Analysis
Best Analysts Covering MDT
1 Year
1 Year Success Rate
19/22 ratings generated profit
1 Year Average Return
+15.14%
reiterated a buy rating 5 months ago
Copying Kristen Stewart's trades and holding each position for 1 Year would result in 86.36% of your transactions generating a profit, with an average return of +15.14% per trade.
---